Viewing Study NCT00262067


Ignite Creation Date: 2025-12-25 @ 12:56 AM
Ignite Modification Date: 2025-12-25 @ 11:10 PM
Study NCT ID: NCT00262067
Status: UNKNOWN
Last Update Posted: 2013-12-13
First Post: 2005-12-02
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
Sponsor: Genentech, Inc.
Organization: